DR. EUGENE MITCHELL LONG M.D. NPI 1477996965

NPI Information

  • NPI: 1477996965
  • Provider Name: DR. EUGENE MITCHELL LONG, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 3696 WHEELER RD
    AUGUSTA, GA
    ZIP 30909
  • Phone: (706) 831-7620

Map and Directions

Get Directions

NPI Details

DR. Eugene Mitchell Long, M.D. is a hematology and oncology internal medicine in Augusta, GA with 12 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Eugene Mitchell Long, M.D. NPI is 1477996965. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:2013

The provider's business location address is:

3696 WHEELER RD
AUGUSTA, GA
ZIP 30909
Phone: (706) 831-7620

The NPI 1477996965 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo), 0.5 mg (HCPCS:Q5120)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Injection, potassium chloride, per 2 meq (HCPCS:J3480)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Iron level (HCPCS:83540)
  • Transferrin (iron binding protein) level (HCPCS:84466)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Folic acid level, rbc (HCPCS:82747)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Smoking and tobacco use intensive counseling, 4-10 minutes (HCPCS:99406)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Urinalysis, manual test (HCPCS:81002)
  • Beta-2 microglobulin (protein) level (HCPCS:82232)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Magnesium level (HCPCS:83735)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Ct scan of chest without contrast (HCPCS:71250)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Uric acid level, blood (HCPCS:84550)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Injection, lorazepam, 2 mg (HCPCS:J2060)
  • Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
  • Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
  • Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free (HCPCS:90674)
  • Administration of influenza virus vaccine (HCPCS:G0008)

The enumeration date for this NPI number is 4/15/2013 and was last updated on 11/14/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology24457GEORGIAYes
2207R00000XInternal Medicine24457MISSISSIPPINo

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.